Status:
COMPLETED
ConquerFear-Group: A Psychological Intervention for Fear of Cancer Recurrence
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
University of Aarhus
Conditions:
Fear of Cancer Recurrence
Breast Cancer Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The primary aim of this randomized controlled trial is to evaluate the effect of ConquerFear-Group (CF-G), compared with a control condition (CC), on Fear of Cancer Recurrence (FCR). Secondary aims ar...
Detailed Description
A randomized controlled trial testing the efficacy of ConquerFear-Group (CF-G) on breast cancer survivors with clinical levels of Fear of Cancer Recurrence (FCR), compared with a control condition (CC...
Eligibility Criteria
Inclusion
- Eligible patients have a confirmed past diagnosis of stage 1-3 breast cancer,
- have been treated with curative intent,
- have completed all hospital-based adjuvant treatments 3 months to 5 years prior to study entry,
- are disease free,
- scores in the clinical range (≥22) on the Short Form of the Fear of Cancer Recurrence Inventory (FCRI-SF),
- are able to read and write Danish,
- are over the age of 18 years, and
- are able to give informed consent.
Exclusion
- self-reported current major depression,
- currently receiving psychological treatment from a therapist not involved in the study,
- self-reported active psychotic illness or other severe psychiatric conditions.
Key Trial Info
Start Date :
October 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2022
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04137575
Start Date
October 21 2019
End Date
June 22 2022
Last Update
June 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark